Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and obesity. Prospective population-based data regarding development and possible predictors of type 2 diabetes (T2D) in PCOS are limited. Design: National Patient Register-based study. Methods: Patients with PCOS [PCOS Denmark and embedded cohort, PCOS Odense University Hospital (OUH)] and a control population with no previous diagnosis of T2D. PCOS OUH (N = 1,162) included premenopausal women with PCOS and standardized clinical and biochemical examination. PCOS Denmark (N = 18,477) included women with PCOS in the Danish National Patient Register. Three age-matched controls were included per patient (N = 54,680). Main outcome: T2D events according to diagnosis codes and filled medicine prescriptions. Results: The median (quartiles) follow-up was 11.1 (6.9 to 16.0) years. The hazard ratio (HR) with 95% confidence interval (CI) for development of T2D in PCOS Denmark was HR = 4.0 (95% CI, 3.7 to 4.3; P < 0.001), and the total event rate of T2D was 8.0 per 1000 person years in PCOS Denmark vs 2.0 per 1000 person years in controls (P < 0.001). The median age at diagnosis of T2D was 31 (26 to 37) years in PCOS Denmark vs 35 (27 to 44) years in controls (P < 0.001). In multiple regression analyses, body mass index, glycated hemoglobin, fasting blood glucose, 2-hour blood glucose, homeostasis model assessment of insulin resistance, and triglycerides were positively associated with development of T2D, whereas higher number of births was negatively associated with development of T2D. Conclusion: The event rate of T2D was higher in PCOS compared with controls, and T2D was diagnosed at a younger age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [10]
In the citing paper
“PCOS is associated with a higher incidence of fertility assistance and complications of pregnancy, including gestational hypertension and diabetes.12,17,18,21, 22, 23, 24”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“In addition, it is recognized that IR plays a major role in the pathophysiology of all of the metabolic diseases, cardiovascular disease, some neurodegenerative diseases, and selected cancers [22,157].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [157]
In the citing paper
“Women with PCOS experience increased cardiometabolic risk—including the metabolic syndrome, hypertension, insulin resistance, obesity and dyslipidemia—predisposing them to increased risk for diabetes and cardiovascular disease (CVD).2,10,17, 18, 19, 20”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 4×
“001 1 3966 (21) 208 (19) 3758 (22) 5324 (10) 62 (6) 5262 (10) 2 4106 (22) 90 (8) 4016 (23) 6494 (12) 24 (2) 6470 (12) $3 31 (3) 31 (3) 1382 (8) 2392 (4) 13 (1) 2379 (4)”
BackgroundInfluentialWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Research works printed but not linked: 1
- 2012, Polycystic ovary syndrome: an update, Aust Fam Physician, 41, 752
Cited by
Items 101–200 of 223
Association Between Polycystic Ovary Syndrome and Risk of Pancreatic Cancer
Peeri, N. C., Landicino, M. V., Saldia, C. A., Kurtz, R. C., Rolston, V. S., & Du, M. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.4540 · Cited by 18
Vine, D. F., Beilin, L. J., Burrows, S., Huang, R.-C., Hickey, M., Hart, R., Proctor, S. D., & Mori, T. A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa061 · Cited by 17
“Women with PCOS are reported to have increased incidence of type-2 diabetes and premature cardiovascular disease (CVD) [1-4].”
BackgroundLi, X., Zhang, T., Li, S., Deng, Y., Wang, L., Tao, T., Wang, S., Gu, Y., Gu, W., Hong, J., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14154 · Cited by 17
Tatulashvili, S., Gusto, G., Cosson, E., Balkau, B., Gourdy, P., Bonnet, F., Bihan, H., & Fagherazzi, G. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13129 · Cited by 17
Testosterone Protects Pancreatic β-cells from Apoptosis and Stress-Induced Accelerated Senescence
Kang, S. M., Jung, H. S., Kwon, M. J., Lee, S. H., & Park, J. H. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200169 · Cited by 17
Mitochondrial DNA 4977 bp Deletion in Peripheral Blood Is Associated With Polycystic Ovary Syndrome
Ye, M., 施伟慧, Hu, B., Guo, F., Lin, X., Li, J., Xu, C., & Li, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.675581 · Cited by 17
Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN)
Mitro, S. D., Waetjen, L. E., Lee, C., Wise, L. A., Zaritsky, E. F., Harlow, S. D., Khoudary, S. R. E., Santoro, N. F., Solomon, D. H., Thurston, R. C., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae625 · Cited by 16
Mínguez‐Alarcón, L., Williams, P. L., James-Todd, T. M., Souter, I. C., Ford, J. B., Rexrode, K. M., Calafat, A. M., Hauser, R. B., & Chavarro, J. E. (2022) · Toxics · doi:10.3390/toxics10060292 · Cited by 16
Zumbro, E. L., Rao, M., Balcom-Luker, S., Broughton, K. S., & LeMieux, M. J. (2021) · Nutrients · doi:10.3390/nu13072451 · Cited by 16
Zhang, L., Wang, Z., Kong, L., Liu, H., Ma, Z., Xu, M., Yushanjiang, S., Yuan, D., & Yu, L. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01415-5 · Cited by 16
Female-specific risk factors for cardiovascular disease: an update
Theodorou, A., Karagiannakis, D. S., Stefanaki, K., Kassi, E., Peppa, Μ., Vryonidou, A., & Paschou, S. Α. (2024) · HORMONES · doi:10.1007/s42000-024-00576-5 · Cited by 16
Sankaranarayanan, L., Brewer, K., Morrow, S., Johnson, G. D., Barrera, A., Venukuttan, R., Sisk, R. K., Dunaif, A. E., & Reddy, T. E. (2025) · Nature Communications · doi:10.1038/s41467-025-62884-7 · Cited by 16
PhenPath: a tool for characterizing biological functions underlying different phenotypes
Babbi, G., Martelli, P. L., & Casadio, R. (2019) · BMC Genomics · doi:10.1186/s12864-019-5868-x · Cited by 14
Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?
Livadas, S., Bothou, C., Kuliczkowska-Płaksej, J., Robeva, R., Vryonidou, A., Macut, J. B., Androulakis, I., Opalic, M., Mouslech, Z., Milewicz, A., et al. (2022) · Endocrine Connections · doi:10.1530/ec-21-0358 · Cited by 13
Multi-omics insights and therapeutic implications in polycystic ovary syndrome: a review
Babu, A., & Ramanathan, G. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01053-9 · Cited by 12
Kothmann, K., Jacobsen, V., Laffitte, E., Bromfield, C. R., Grizzaffi, M., Jarboe, M., Braundmeier‐Fleming, A., Bahr, J. M., Nowak, R. A., & Newell‐Fugate, A. E. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2020 · Cited by 12
Vine, D. F., Proctor, E., Weaver, O. R., Ghosh, M., Maximova, K., & Proctor, S. D. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab114 · Cited by 11
Bries, A. E., Webb, J. L., Vogel, B., Carrillo, C. A., Keating, A. F., Pritchard, S. K., Roslan, G. R., Miller, J. W., & Schalinske, K. L. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab038 · Cited by 11
A Comprehensive Review on Treatments for Polycystic Ovarian Syndrome (PCOS)
Patel, A., Jacob, A., Thomas, R., Plavumkal, H., Sneed, K. B., & Pathak, Y. V. (2024) · Nursing & Primary Care · doi:10.33425/2639-9474.1265 · Cited by 11
ViT-PCOS: Vision Transformer for Automated Polycystic Ovary Syndrome Detection
Sri, P. L., Madhumita, M., Madhuraj, T., Goel, A., Aadharsh Aadhithya, A., & Soman, K. P. (2024) · International Conference on Emerging Frontiers in Electrical and Electronic Technologies (ICEFEET) · doi:10.1109/icefeet64463.2024.10866446 · Cited by 11
Ивановна, А. Е., Shalina, M. A., Владимировна, М. Е., Tkachenko, N. N., & Bulgakova, O. L. (2019) · Journal of obstetrics and women s diseases · doi:10.17816/jowd6837-14 · Cited by 11
Udesen, P. B., Sørensen, A. E., Joglekar, M. V., Hardikar, A. A., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0478-7 · Cited by 10
Wu, X., Wilke, M., Batara, J., Proctor, S. D., Cree‐Green, M., Ghosh, M., Raggi, P., Windram, J. D., Becher, H. H., & Vine, D. F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520922 · Cited by 10
Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome
Ollila, M., Hautakoski, A., Arffman, M., Morin-Papunen, L. C., Koivikko, M. L., Ebeling, T., Sund, R., & Piltonen, T. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf026 · Cited by 10
Glintborg, D., Petersen, T. G., Rubin, K. H., & Andersen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10102396 · Cited by 10
Self-citationSilveira, A. O. S. M., Gomides, M. D. A., & Sadoyama, G. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000541 · Cited by 10
Si, M., Jiang, H., Zhao, Y., Qi, X., Li, R. P., Long, X., & Qiao, J. (2023) · Diagnostics · doi:10.3390/diagnostics13111927 · Cited by 10
Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes
Actkins, K. V., Jean-Pierre, G., Aldrich, M. C., Edwards, D. R. V., & Davis, L. K. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010764 · Cited by 8
Risk Factors for Incident Polycystic Ovary Syndrome Diagnosis
Christ, J. P., Yu, O., Barton, B. E., Schulze‐Rath, R., Grafton, J. R., Cronkite, D., Covey, J., Kelley, A., Holden, E., Hilpert, J., et al. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0741 · Cited by 8
Cardiovascular health and menopause in aging women with polycystic ovary syndrome
Helvacı, N., & Yıldız, B. O. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1719067 · Cited by 8
Potassium levels in women with polycystic ovary syndrome using spironolactone for long‐term
deOliveira, T. A., Marchesan, L. B., & Spritzer, P. M. (2023) · Clinical Endocrinology · doi:10.1111/cen.15008 · Cited by 8
Atkins, P., TOMLINSON, G. A., Feig, D. S., & MiTy Collaborative Group (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3713 · Cited by 8
Jafari, K., Tajik, N., Moini, A., SeyedAlinaghi, S., & Abiri, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-01287-6 · Cited by 7
Ollila, M., Piltonen, T., Tapanainen, J. S., & Morin-Papunen, L. C. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.010 · Cited by 7
Sukhapure, M. (2019) · Otago University Research Archive (University of Otago) · Cited by 7
Fasting Versus Non-Fasting Total Testosterone Levels in Women During the Childbearing Period
Ali, E. B., Hamza, A., Zaboon, I. A., Alidrisi, H. A., & Mansour, A. A. (2023) · Cureus · doi:10.7759/cureus.35462 · Cited by 6
Peecher, D. L., Binder, A. K., & Gabriel, K. I. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy233 · Cited by 6
Modern aspects of management of patients with polycystic ovary syndrome
Авраменко, Н. В., Кабаченко, О. В., Барковський, Д. Є., & Sierykh, К. (2020) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2020.6.218474 · Cited by 6
Witham, M., & Hengel, S. R. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae010 · Cited by 6
Melo, R. R., Pontes, A. G., Delmanto, L. R. M. G., Bueloni-Dias, F. N., Véspoli, H. D. L., & Nahás, E. A. P. (2023) · Clinical Endocrinology · doi:10.1111/cen.14982 · Cited by 5
Jianli, S., Guan, Z., Ji, G., Wang, J., Yan, X., Zhang, Y., Zhang, Y., Ha, C., Hu, R., Chang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202508240 · Cited by 5
Taghipour, F., Samadian, H., Dalirfardouei, R., Asl, S. S., Barati, N., & Artimani, T. (2025) · Steroids · doi:10.1016/j.steroids.2025.109688 · Cited by 5
Begum, I. A., Hosen, A. S. M. S., Ghimire, D., & Park, M. J. (2025) · Diagnostics · doi:10.3390/diagnostics15060711 · Cited by 5
Síndrome de ovario poliquístico
Bachelot, A. (2024) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(24)49087-9 · Cited by 4
Self-reported history of comorbidities and markers of ovarian reserve among subfertile women
Mínguez‐Alarcón, L., Hammer, K. C., Williams, P. L., Souter, I. C., Ford, J. B., Rexrode, K. M., Hauser, R. B., Chavarro, J. E., & for the Earth Study Team (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02643-5 · Cited by 4
Gohary, D. S. E. E., Ismail, M. M., Khayat, A. M. E., & Elbohoty, S. B. (2023) · Journal of Medicine in Scientific Research · doi:10.59299/2537-0928.1025 · Cited by 4
Kılıç, D., Güler, T., & Alataş, E. (2020) · Pamukkale Medical Journal · doi:10.31362/patd.641770 · Cited by 4
Metabolic Implications of PCOS
Naveed, A., Shah, R., Bernier, A., Muradova, V., Gurol, E. S., Cree‐Green, M., & Whooten, R. (2025) · Current Pediatrics Reports · doi:10.1007/s40124-025-00364-8 · Cited by 3
Mohanapu, S., & Jeyakumar, A. M. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20191544 · Cited by 3
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.gp127 · Cited by 3
Self-citationThe Molecular Basis of Polycystic Ovary Syndrome: Genetics, Epigenetics and Insulin Resistance
Hiam, D. (2018) · Victoria University Research Repository (Victoria University) · Cited by 3
Metabolic health outcomes among women with polycystic ovary syndrome
Kumarendran, B. (2024) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 3
Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome
Zhang, Y., Zhao, T., Hu, L., & Xue, J. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01259-z · Cited by 3
Yurtseven, K., Akbaba, A. K., Pınarlı, Ç., İbanoğlu, M. C., & Üstün, Y. E. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04628-3 · Cited by 2
Romualdi, D., Versace, V., Lanzone, A., & Longhi, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-031-31307-3_16 · Cited by 2
Diagnostik der Androgenisierung am Beispiel „funktionell androgenisierendes Syndrom III“ (≈„PCOS“)
Geisthövel, F., & Geisthövel, M. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-04522-0 · Cited by 2
Sydora, B. C., Wilke, M. S., Ghosh, M., & Vine, D. F. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s504439 · Cited by 2
Evaluation of Sleep Disturbances in Women with Polycystic Ovary Syndrome
Krishnan, N., Suganya., B., & Hemamalini, A. J. (2024) · International Journal of Infertility & Fetal Medicine · doi:10.5005/jp-journals-10016-1341 · Cited by 2
Kite, C., Kyrou, I., Randeva, H. S., Lahart, I. M., & Brown, J. E. P. (2025) · Women s Health · doi:10.1177/17455057251385800 · Cited by 2
The Long-Term Health Consequences of Polycystic Ovary Syndrome
Owens, L. A., & Franks, S. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.018 · Cited by 2
Zaidieva, Y. Z., Balan, V. E., & Tsar’kova, A. V. (2023) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20232306125 · Cited by 2
Glintborg, D., Møller, J. K., Rubin, K. H., Christensen, L. L., & Andersen, M. (2025) · Clinical Endocrinology · doi:10.1111/cen.70019 · Cited by 2
Self-citationSelf-monitoring of blood glucose, practices, and determinants in type 2 diabetics
Salih, A. A., Sadiq, M. A., & Rayed, M. H. (2021) · Preventive Medicine and Community Health · doi:10.15761/pmch.1000157 · Cited by 2
Glycemic status-dependent proteomic signatures of biological aging for health risk prediction
Li, J., Li, J., Xu, X., Yu, Y., Shen, W., Sun, Y., Fu, Y., Tan, X. W., Wang, N., Lu, Y., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01950-w · Cited by 2
Livadas, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02051 · Cited by 2
Neuroendocrine androgen actions in the origins of polycystic ovary syndrome
Sucquart, I. E. (2023) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/25419 · Cited by 2
Impact of polycystic ovary syndrome on methyl group metabolism
Bries, A. E. (2020) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210114-18 · Cited by 1
PCOS – aktuelle „ESHRE guideline“
Magaton, I. M. (2019) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-019-0090-4 · Cited by 1
Polycystic ovary syndrome and cardiovascular risk
Popova, P., Gorelova, I. V., & Grineva, E. N. (2019) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2018-24-6-654-665 · Cited by 1
Ивановна, А. Е., Yarmolinskaya, M. I., Bulgakova, O. L., Владимировна, М. Е., Tkachenko, N. N., & Borodina, V. L. (2022) · Russian Journal of Human Reproduction · doi:10.17116/repro20222804131 · Cited by 1
A importância da melatonina na síndrome dos ovários policísticos: Uma revisão bibliográfica
do Nascimento, R. P., Silva, M. G. D. S., do Carmo, L. B., & Peres, M. C. T. D. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i6.28483 · Cited by 1
Himanshu, Verma, S., Yadav, S., Singh, A., Chauhan, J., Sameeksha, Sahu, K., & Mamgain, A. K. (2026) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-026-00025-4
Hellebaut, S., Meerschaut, F. V., & Vandekerckhove, F. (2020) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.76.20.039
Yu, C., Sun, Z., Wu, Q., Zhou, Z., Chen, W., & Xu, B. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1932335
Macchione, R. F. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2023.tde-08082023-143833
Sindrome dell’ovaio polimicrocistico
Bachelot, A. (2024) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(24)49206-1
Urbanetz, L. A. M. L. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2024.tde-05082024-124157
Sydora, B. C., Ghosh, M., Chambers, S., Haase, A., Davenport, M. H., Beaulieu, C., Thompson, R. B., Windram, J., Becher, H., Raggi, P., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124025
Bass, I. R., Nosova, E. V., & Dunaif, A. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00085-8
Benham, J. L., Cannon, S., Cadogan, K., Botkin, H. C., Dolatabadi, S., Stafl, L., & Yamamoto, J. M. (2026) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2026.03.003
Vine, D. F., Moran, L., Teede, H. J., & Khomami, M. B. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100734
Thabit, W. A., Hassan, F. A., Obaid, J. M. A. S., Abdo, Z. M., & Yousef, B. M. (2026) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2026.2698149
A Paixón e a Semana Santa en Galicia: coñecemento do medio cultural galego
Gómez, F. S. L. (2002) · Dialnet (Universidad de la Rioja)
A MODERN VIEW OF THE POLYCYSTIC OVARIAN SYNDROME
BRAGA, M., Bordea, E. A., Brătilă, E., Marinescu, B., & Carp-Velişcu, A. (2020) · Annals of the Academy of Romanian Scientists Series of Medicine · doi:10.56082/annalsarscimed.2020.1.5
Sydora, B. C., Wilke, M. S., McPherson, M., Chambers, S. A., Ghosh, M., & Vine, D. F. (2024) · Figshare · doi:10.6084/m9.figshare.26635785
Cardozo, L. L. Y., Eissa, M., Basnet, J., Thompson, K., & Romero, D. G. (2026) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2026.10.006
Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
Tan, S., Böing, C., & Führer‐Sakel, D. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-0891-9131
Cheng, X., Li, Y., Zhu, M., 蔡亞潔, Wei, N., Liu, Y., & Liu, Y. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.10.002
A Lifecourse Perspective on Polycystic Ovary Syndrome (PCOS): Bridging Gaps in Research and Practice
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7544-4
Role of Epigenetics in Painting the Landscape of PCOS
Sharma, M., Taneja, A., Halder, A., & Devi, N. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010018
Spritzer, P. M., Ramos, R. B., Marchesan, L. B., de Oliveira, M., & Carmina, E. (2021) · Figshare · doi:10.6084/m9.figshare.14053311
Kamila, G. (2026) · Journal of chemical health risks
Aggiornamento delle Linee Guida della sindrome dell’ovaio policistico
Maseroli, E., Stasi, V. D., Cipriani, S., & Vignozzi, L. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01575-3
Polycystic ovary syndrome and maternal obesity : does it programme transgenerational dysfunction?
Lu, H. (2024) · Open Archive (Karolinska Institutet)
A Deep Dive into Polycystic Ovary Syndrome: A Multidisciplinary Approach
Suvvari, T. K., Silva, R. G. D., Sree, P. C., Kandi, V., Shaik, A. F., & Kutikuppala, L. V. S. (2023) · Apollo Medicine · doi:10.4103/am.am_50_23
Oliveira, T. A. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M.
- Affiliations
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Corresponding author
- Glintborg, Dorte
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-08-29
- Volume
- 102
- Issue
- 10
- Pages
- 3848-3857
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2751209738
- Cited by
- 195
- References
- 44
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 18 · 2023: 28 · 2022: 26 · 2021: 30 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 1
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, type 2 diabetes, diabetes risk factors, insulin resistance, body mass index, HbA1c, fasting blood glucose, HOMA-IR, triglycerides, parity, age at diabetes diagnosis, premenopausal women
- MeSH terms
- Adolescent, Adult, Child, Denmark, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Middle Aged, Polycystic Ovary Syndrome, Registries, Risk Factors, Case-Control Studies, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.